financetom
Business
financetom
/
Business
/
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
Feb 4, 2025 6:34 AM

Feb 4 (Reuters) - The U.S. Food and Drug Administration

has approved Supernus Pharmaceuticals' ( SUPN ) drug-device

combination to treat movement-related symptoms of Parkinson's

disease, the drugmaker said on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved